antibody gene therapy (Johns Hopkins Bloomberg School of Public Health/Ragon Institute/the California Institute of Technology)

N/A

Report date: 2025/03/14 16:33:57

Base Information

Drug Nameantibody gene therapy (Johns Hopkins Bloomberg School of Public Health/Ragon Institute/the California Institute of Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapyBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins Bloomberg School Of Public Health
China Registration ClassN/A

Develop Information

Active CompaniesThe Ragon Institute of MGHJohns Hopkins Bloomberg School Of Public HealthCalifornia Institute Of Technology
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A